Skip to Content

Cancers, Volume 17, Issue 24

2025 December-2 - 150 articles

Cover Story: Chimeric antigen receptor (CAR)-based therapies are rapidly evolving, particularly in challenging diseases such as acute myeloid leukemia (AML). This review summarizes recent advances in CAR engineering aimed at improving specificity, safety, and efficacy, including modular receptor architectures, logic-gated activation strategies, functional armoring approaches, gene-editing technologies, and emerging CAR platforms based on alternative immune cell types beyond conventional T-cell therapies. We highlight how these fine-tuned designs may reshape cellular immunotherapy strategies against AML and guide future development toward more controlled, adaptable, and personalized immune cell therapies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (150)

  • Review
  • Open Access
782 Views
18 Pages

HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis

  • Antonio Giorgio,
  • Massimo De Luca,
  • Anna Lombardi,
  • Emanuela Ciracì,
  • Valeria Cosima Rollo,
  • Antonella Di Sarno,
  • Luca Montesarchio,
  • Giuseppe Stella and
  • Valentina Giorgio

18 December 2025

Conventional ultrasound (US) has long been central to hepatocellular carcinoma (HCC) surveillance in cirrhotic patients, due to its low cost, wide availability, non-invasiveness, and adequate sensitivity for detecting small nodules. However, its spec...

  • Article
  • Open Access
624 Views
17 Pages

MRI-Derived Body Composition and Breast Cancer Risk in Postmenopausal Women: UK Biobank Study

  • Livingstone Aduse-Poku,
  • Lusine Yaghjyan,
  • Stephen E. Kimmel,
  • Susmita Datta,
  • Shama D. Karanth,
  • Jae Jeong Yang,
  • Caretia Washington and
  • Dejana Braithwaite

18 December 2025

Background: Obesity is a risk factor for breast cancer mortality in postmenopausal women. However, it remains unclear which specific components of adipose tissue and skeletal muscle are associated with risk. This study assessed the associations betwe...

  • Article
  • Open Access
474 Views
23 Pages

Exploration of Predictive Factors for Acute Radiotherapy-Induced Gastro-Intestinal Symptoms in Prostate Cancer Patients

  • Pauline De Bruyn,
  • Malgorzata Klass,
  • Alain Van Muylem,
  • Nicolas Jullian,
  • François-Xavier Otte,
  • Romain Diamand and
  • Jean-Charles Preiser

18 December 2025

Background: Acute gastrointestinal (GI) toxicity is a frequent adverse effect of pelvic radiotherapy (RT) in prostate cancer and predicts chronic complications. Identifying predictive factors, especially modifiable ones, is essential to guide support...

  • Article
  • Open Access
842 Views
11 Pages

18 December 2025

Objective: This study aimed to investigate annual and seasonal trends, as well as regional differences, in female breast cancer mortality in Hungary between 2004 and 2023. Methods: Data on cancer mortality were obtained from the publicly available na...

  • Review
  • Open Access
559 Views
32 Pages

Silent Players, Loud Impact: The Influence of lncRNAs on Melanoma Progression

  • Kajetan Kiełbowski,
  • Maciej Ćmil,
  • Aleksandra Dach,
  • Aleksandra Cole,
  • Oliwia Jerzyńska,
  • Estera Bakinowska,
  • Paulina Plewa and
  • Andrzej Pawlik

18 December 2025

Non-coding RNA (ncRNA) encompasses a large family of molecules that are crucial regulators of gene expression. This family includes microRNA, piwi-interacting RNA, and long non-coding RNA (lncRNA); each class is associated with different mechanisms o...

  • Review
  • Open Access
597 Views
11 Pages

Would Biopsy Change the Management of Kidney Cancer in the Coming Decade? The Role of Biopsy in Small Renal Masses: A Narrative Review

  • Łukasz Dariusz Lisak,
  • Paweł Hełka,
  • Aleksandra Kaźmierczak,
  • Anna Kaletka,
  • Sarah Sampers,
  • Piotr Kania,
  • Miłosz Jasiński and
  • Maciej Salagierski

18 December 2025

Renal cell carcinoma (RCC) is the 14th-most common cancer worldwide, with 434,419 new cases recorded in 2022 [...]

  • Article
  • Open Access
1 Citations
477 Views
13 Pages

Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort

  • Elena Jane Mason,
  • Alba Di Leone,
  • Beatrice Carnassale,
  • Antonio Franco,
  • Cristina Accetta,
  • Sabatino D’Archi,
  • Flavia De Lauretis,
  • Federica Gagliardi,
  • Elisabetta Gambaro and
  • Gianluca Franceschini
  • + 17 authors

18 December 2025

Background: Pregnancy-associated breast cancer (PABC), defined as breast cancer diagnosed during pregnancy or within one year postpartum, is a unique and clinically challenging entity. Evidence suggests that tumors diagnosed during pregnancy (PrBC) a...

  • Article
  • Open Access
672 Views
17 Pages

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

  • Agnieszka Tomaszewska,
  • Grzegorz W. Basak,
  • Christophe Peczynski,
  • Emmanuelle Polge,
  • Pascale Ambron,
  • William Boreland,
  • Simona Sica,
  • Mutlu Arat,
  • Jakob Passweg and
  • Zinaida Perić
  • + 12 authors

18 December 2025

Background: Haploidentical hematopoietic cell transplantations (haplo-HCTs) with post-transplant cyclophosphamide (PT-Cy) are standard practice, but complications causing morbidity and mortality are not well described. Methods: The aim of this prospe...

  • Article
  • Open Access
615 Views
11 Pages

Impact of Frailty on the Outcomes of Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy

  • Nicholas R. Williams,
  • Thomas Leuschner,
  • Amanda K. Walsh,
  • Kayla Gault,
  • Amber Ingram,
  • Alex B. Blair,
  • Susan Tsai,
  • Timothy M. Pawlik,
  • Mary E. Dillhoff and
  • Jordan M. Cloyd

18 December 2025

Background: Neoadjuvant therapy (NT) is increasingly utilized for patients with localized pancreatic ductal adenocarcinoma (PDAC). Toxicities during NT are common, often leading to the inability to undergo surgical resection, yet risk factors for att...

  • Article
  • Open Access
595 Views
17 Pages

18 December 2025

Background: Appendiceal neoplasms are rare, but recent data indicate a rising trend, particularly in patients under the age of 50. These tumours are often diagnosed incidentally during histopathological examination. This study has aimed to examine th...

  • Article
  • Open Access
759 Views
20 Pages

Associations of Breast Cancer Treatments with One-Year Changes in Health-Related Fitness

  • Fernanda Z. Arthuso,
  • Ki-Yong An,
  • Qinggang Wang,
  • Renée L. Kokts-Porietis,
  • Andria R. Morielli,
  • Margaret L. McNeely,
  • Jeff K. Vallance,
  • S. Nicole Culos-Reed,
  • Gordon J. Bell and
  • Kerry S. Courneya
  • + 7 authors

17 December 2025

Background/Objectives: Early-stage breast cancer treatments adversely affect components of health-related fitness (HRF) important for treatment tolerability, recovery, and long-term outcomes. Few studies have examined cancer treatment modality-specif...

  • Article
  • Open Access
681 Views
14 Pages

Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)

  • Maria Elena Carazzolo,
  • Francesca Maria Quaglia,
  • Antonino Aparo,
  • Alessia Moioli,
  • Alice Parisi,
  • Riccardo Moia,
  • Francesco Piazza,
  • Alessandro Re,
  • Maria Chiara Tisi and
  • Carlo Visco
  • + 18 authors

17 December 2025

Background: Mantle Cell Lymphoma (MCL) is an aggressive malignancy with variable clinical behavior, largely reflecting the underlying molecular heterogeneity. The genomic landscape of MCL encompasses gene mutations with strong prognostic implications...

  • Article
  • Open Access
945 Views
22 Pages

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models

  • Anton K. Gorbushin,
  • Natalia A. Luzan,
  • Victoriya D. Kakhanova,
  • Anastasia A. Koshmanova,
  • Daniil S. Grek,
  • Ivan I. Voronkovskii,
  • Vladislav M. Farniev,
  • Elvira. S. Melikhova,
  • Kirill A. Lukyanenko and
  • Anna S. Kichkailo
  • + 14 authors

17 December 2025

Background: With the rising incidence of cancer, there is a growing need for improved preclinical models to test new therapies. While patient-derived xenografts (PDX) in immunodeficient mice are the gold standard, they are costly and result in a comp...

  • Review
  • Open Access
1 Citations
2,091 Views
28 Pages

The Impact of Senescence-Associated Secretory Phenotype (SASP) on Head and Neck Cancers: From Biology to Therapy

  • Md Tanjim Alam,
  • Mishfak A. M. Mansoor,
  • Sarah A. Ashiqueali,
  • Pawel Golusinski,
  • Ewelina Golusinska-Kardach,
  • Joanna K. Strzelczyk,
  • Blazej Rubis,
  • Wojciech Golusinski and
  • Michal M. Masternak

17 December 2025

Cellular senescence is defined as a state of permanent cell cycle arrest, providing a natural barrier against cancer. However, senescent cells are very metabolically active and secrete a complex mixture of bioactive molecules collectively known as th...

  • Article
  • Open Access
1 Citations
669 Views
18 Pages

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece—The TRINITY Study

  • Konstantinos Papazisis,
  • Christos Christodoulou,
  • Flora Zagouri,
  • Ippokratis Korantzis,
  • Ioannis Boukovinas,
  • Anna Koumarianou,
  • Angelos Koutras,
  • Eleni Timotheadou,
  • Giannis Mountzios and
  • Emmanouil Saloustros
  • + 8 authors

17 December 2025

Background: Guidelines recommend neoadjuvant systemic therapy (NST) as the preferred treatment approach for stage II–III triple-negative breast cancer (TNBC), an aggressive form of breast cancer (BC) that lacks specific therapeutic targets. Thi...

  • Review
  • Open Access
1,260 Views
22 Pages

Insomnia in Women Surviving Breast and Gynecological Cancers—A Narrative Review to Address the Hormonal Factor

  • Silvia Martella,
  • Paola Proserpio,
  • Maria Elena Guerrieri,
  • Andrea Galbiati,
  • Luigi Ferini-Strambi,
  • Laura Cucinella,
  • Anna Daniela Iacobone,
  • Dorella Franchi and
  • Rossella E. Nappi

17 December 2025

Female cancers, including breast and gynecological malignancies, are among the most prevalent oncological conditions worldwide. Advances in screening, diagnosis, and treatment have markedly improved survival, resulting in a growing population of fema...

  • Review
  • Open Access
2 Citations
2,362 Views
26 Pages

17 December 2025

Approximately 80% of invasive breast cancers are classified as human epidermal growth factor receptor 2 (HER2)-negative; however, many of these tumors have detectable levels of HER2 surface expression. Trastuzumab deruxtecan (T-DXd) is a HER2-directe...

  • Review
  • Open Access
970 Views
38 Pages

Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives

  • Martina Delsignore,
  • Gaia Cassinari,
  • Simona Revello,
  • Luigi Cerbone,
  • Federica Grosso,
  • Marcello Arsura and
  • Chiara Porta

17 December 2025

Diffuse pleural mesothelioma (PM) is a rare thoracic malignancy with historically limited treatment options and poor outcomes. Despite the recent breakthrough of dual immune checkpoint blockade (ICB)—notably the combination of anti-PD-1 and ant...

  • Review
  • Open Access
2 Citations
1,465 Views
30 Pages

Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges

  • Justine Maes,
  • Bernard Pôlet,
  • Janke Kleynhans,
  • Filip Van Herpe,
  • Karolien Goffin,
  • Jeroen Dekervel,
  • Philippe Nafteux,
  • Baki Topal,
  • Frederik Cleeren and
  • Christophe M. Deroose

17 December 2025

Fibroblast activation protein (FAP)-binding radiopharmaceuticals have emerged as promising candidates for both diagnostic and therapeutic applications in oncology due to their selective targeting of cancer-associated fibroblasts (CAFs). This review e...

  • Article
  • Open Access
502 Views
13 Pages

In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma

  • Kaitlyn H. Smith,
  • Erin M. Trovillion,
  • Kimberly Q. McKinney,
  • Poornima Gourabathini,
  • Kenzie Wells,
  • Divya Gandra,
  • Chloe Sholler,
  • Ingrid Votruba,
  • Javier Oesterheld and
  • Giselle L. Saulnier Sholler

17 December 2025

Background: Ewing sarcoma (ES) is an aggressive malignancy and there is an unmet need for more effective treatment options for patients. Histone deacetylases (HDACs) have been shown to be involved in ES tumorigenesis and HDAC inhibitors have been inv...

  • Article
  • Open Access
520 Views
16 Pages

Synergistic Disruption of Survival and Metastatic Potential in Esophageal Adenocarcinoma Cells Through Combined Inhibition of HIF1α and CD73

  • Ian Mersich,
  • Alexander Malmberg,
  • Eahsanul Anik,
  • Md Sazzad Hassan,
  • Urs von Holzen,
  • Brian S. J. Blagg and
  • Aktar Ali

17 December 2025

Background/Objectives: Hypoxia promotes esophageal adenocarcinoma (EAC) aggressiveness through stabilization of hypoxia-inducible factor-1α (HIF-1α), which regulates pro-survival, pro-metastatic, and immunosuppressive pathways, including...

  • Review
  • Open Access
1,437 Views
16 Pages

The Management of Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives

  • Antonio Cigliola,
  • Brigida Anna Maiorano,
  • Doga Dengur,
  • Valentina Tateo,
  • Chiara Mercinelli,
  • Michela Piacentini,
  • Sara Inguglia,
  • Carlo Messina and
  • Andrea Necchi

17 December 2025

Background: Muscle-invasive bladder cancer (MIBC) represents a highly aggressive malignancy associated with significant morbidity and mortality. The current standard treatment, which includes radical cystectomy and platinum-based chemotherapy, is bur...

  • Article
  • Open Access
765 Views
17 Pages

Diagnostic Algorithm for Secondary Extramammary Paget Disease from Institutional Cases and Literature Review

  • Salin Kiratikanon,
  • Ayaka Fukui,
  • Masahiro Hirata,
  • Jakob M. T. Moran,
  • Masakazu Fujimoto and
  • Mai P. Hoang

17 December 2025

Background/Objectives: Although clinicopathologic correlation with integration of clinical and radiographic data is the gold standard in distinguishing primary extramammary Paget disease (EMPD) from secondary EMPD, immunoprofiling of EMPD tumors enab...

  • Article
  • Open Access
464 Views
21 Pages

The Role of High-Dose-Rate Brachytherapy (Interventional Radiotherapy) in the Reirradiation of Liver Metastases

  • Paweł Cisek,
  • Izabela Kordzińska-Cisek,
  • Aleksandra Kozłowska and
  • Ludmiła Grzybowska-Szatkowska

16 December 2025

Background: This study aimed to analyse treatment outcomes, determine prognostic factors and assess the toxicity of reirradiation using high-dose-rate (HDR) brachytherapy for liver metastases in the oligometastatic stage of disease. Materials and Met...

  • Review
  • Open Access
945 Views
27 Pages

16 December 2025

Uterine mesenchymal tumors encompass a diverse and diagnostically challenging group of neoplasms, including smooth muscle tumors, endometrial stromal tumors (ESS), perivascular epithelioid cell tumors (PEComas), inflammatory myofibroblastic tumors (I...

  • Review
  • Open Access
537 Views
34 Pages

Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities

  • Vanesa Cabeza-Fernández,
  • Francisco Javier Ríos-Sola,
  • David Martín-Oliva,
  • Jerónimo Borrego-Pérez,
  • Francisco Javier Oliver,
  • José YéLamos and
  • José Manuel Rodríguez-Vargas

16 December 2025

The poly(ADP-ribose) polymerase (PARP) family constitutes a major group of proteins and enzymes essential for the maintenance of cellular homeostasis under physiological conditions and plays a pivotal role in the onset and progression of multiple pat...

  • Article
  • Open Access
607 Views
16 Pages

Comparative Analysis of Bone Marrow, cfDNA and CTCs for NGS-Based Multiple Myeloma Detection: A Pilot Study Indicating the Potential of CTCs

  • Wouter De Brouwer,
  • Robbe Heestermans,
  • Jona Van der Straeten,
  • Kiara Falise,
  • Ann De Becker,
  • Isabelle Vande Broek,
  • Rik Schots,
  • Marleen Bakkus and
  • Ivan Van Riet

16 December 2025

Background/Objectives: Minimal residual disease (MRD) persists in most multiple myeloma (MM) patients, causing relapse despite deep remissions. Repeatability of MRD detection in MM bone marrow (BM) samples is limited, underscoring the need for blood-...

  • Article
  • Open Access
753 Views
17 Pages

The Outcome and Impact of Academic Cancer Clinical Trials with Participation from Canadian Sites (2015–2024)

  • Rebecca Y. Xu,
  • Diana Kato,
  • Victoria Percival,
  • James Schoales,
  • Stephen Sundquist,
  • Raisa Chowdhury,
  • Gregory R. Pond and
  • Janet E. Dancey

16 December 2025

Background/Objectives: Academically sponsored cancer clinical trials (ACCTs) are essential for advancing patient-centered care, particularly in areas underserved by commercial research. The Canadian Cancer Clinical Trials Network (3CTN) was establish...

  • Article
  • Open Access
647 Views
14 Pages

16 December 2025

Background: Although triple-negative breast cancer (TNBC) patients commonly receive adjuvant chemotherapy after surgery, their prognoses vary. This study aimed to investigate how the intrinsic subtypes of TNBCs and immune status of patients affect th...

  • Article
  • Open Access
549 Views
20 Pages

16 December 2025

Objectives: There is high interest in blood-based assays for tracking treatment efficacy and detecting recurrence among breast cancer patients. This preliminary feasibility study assessed the performance of the Early Detection Serum-based Assay for B...

  • Review
  • Open Access
1,088 Views
13 Pages

Early Detection and Prevention of Ovarian Cancer

  • Lauren Montemorano,
  • Laura Huffman and
  • Lisa Barroilhet

16 December 2025

Background/Objectives: Epithelial ovarian cancer (EOC) encompasses ovarian, fallopian tube and peritoneal malignancies. It is a deadly disease and is rarely cured when diagnosed at advanced stages. Early-stage disease is often curable, but clinicians...

  • Article
  • Open Access
527 Views
15 Pages

Assessment of Network Integrity in Right-Hemispheric Glioma Patients Using Function-Based Tractography and Domain-Specific Cognitive Testing

  • Maximilian Schwendner,
  • Leonie Kram,
  • Johanna Lackner,
  • Haosu Zhang,
  • Sandro M. Krieg and
  • Sebastian Ille

16 December 2025

Objective: Gliomas disrupt functional brain networks and impair neurological functions. While left-hemispheric tumors are well-studied because of their impact on language domains, the influence of right-sided gliomas on higher cognitive functions rem...

  • Article
  • Open Access
380 Views
15 Pages

The White Plane in Esophageal Surgery: A Novel Anatomical Landmark with Prognostic Significance

  • Vladimir J. Lozanovski,
  • Timor Roia,
  • Edin Hadzijusufovic,
  • Yulia Brecht,
  • Franziska Renger,
  • Hauke Lang and
  • Peter P. Grimminger

16 December 2025

Introduction: Identification of the thoracic duct (TD) is essential during esophageal surgery to reduce the risk of complications such as chylothorax. The clinical significance of the white plane, or Morosow’s ligament—a consistent anatom...

  • Review
  • Open Access
900 Views
16 Pages

16 December 2025

Triple-negative breast cancer (TNBC) has the poorest prognosis among all breast cancer subtypes, largely due to the lack of targeted therapies and its resistance to both chemotherapy and immunotherapy. A deeper understanding of TNBC biology is theref...

  • Article
  • Open Access
448 Views
12 Pages

16 December 2025

Objective: This study aimed to assess the impact of the number of metastatic lymph nodes (LNs) on survival and propose a subdivision of the N2b category in colorectal cancer (CRC) patients. Methods: We retrospectively analyzed from two sources: clini...

  • Article
  • Open Access
571 Views
18 Pages

Tumoral and Peritumoral Radiomics for Preoperative Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma

  • Filippo Tommaso Gallina,
  • Sonia Lucchese,
  • Antonello Vidiri,
  • Francesca Laganaro,
  • Sergio Ruggiero,
  • Doriana Vergara,
  • Riccardo Tajè,
  • Edoardo Mercadante,
  • Paolo Visca and
  • Simona Marzi

16 December 2025

Background:The presence of visceral pleural invasion (VPI) is associated with increased risk of recurrence and reduced overall survival following surgical resection. We aimed to develop machine learning (ML)-based classification models that integrate...

  • Article
  • Open Access
846 Views
22 Pages

Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration

  • Alisa Timiryasova,
  • Lauren Greenberg,
  • Pere Domingo,
  • Philip E. Tarr,
  • Alexander Egle,
  • Charlotte Martin,
  • Cristina Mussini,
  • Ferdinand Wit,
  • Antonella Cingolani and
  • on behalf of the D:A:D and RESPOND Study groups
  • + 16 authors

16 December 2025

Background/Objectives: Whilst cancer is a leading cause of death in people with HIV, less is known about clinical outcomes after cancer. Methods: Participants from the RESPOND and D:A:D cohorts with the five most common cancers (Kaposi’s sarcom...

  • Article
  • Open Access
490 Views
14 Pages

Prediction of Lymphovascular Invasion in Early–Stage Lung Adenocarcinoma Using Artificial Intelligence–Based Radiomics

  • Yoshihisa Shimada,
  • Kazuharu Harada,
  • Yujin Kudo,
  • Jinho Park,
  • Jun Matsubayashi,
  • Masataka Taguri and
  • Norihiko Ikeda

15 December 2025

Objectives: This study utilized artificial intelligence (AI)–based radiomics analysis of computed tomography (CT) images using a modified U–Net for lung nodule segmentation and convolutional neural network based on VGG–16 to predict...

  • Article
  • Open Access
817 Views
18 Pages

15 December 2025

Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy, often diagnosed at advanced stages with poor survival outcomes. Homologous recombination (HR), a major DNA double-strand break (DSB) repair pathway, saf...

  • Review
  • Open Access
1,142 Views
26 Pages

15 December 2025

CDK4/6 inhibitors exert effective anti-tumor effects by blocking the cell cycle and, as a result, have become vital in the systemic treatment of malignant tumors. Previous research has indicated that CDK4/6 inhibitors not only exert effects on the ce...

  • Systematic Review
  • Open Access
582 Views
26 Pages

Single Nucleotide Polymorphisms as Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review

  • Katarzyna Połomska,
  • Magda Rybicka,
  • Adrianna Jażdżewska,
  • Magdalena Prud,
  • Stefania Jackowska,
  • Jaroslaw Kobiela and
  • Piotr Spychalski

15 December 2025

Background: Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal cancer, but only 15–30% of patients achieve a pathological complete response. Single nucleotide polymorphisms represent stable genetic marker...

  • Article
  • Open Access
640 Views
16 Pages

The Impact of Demographic and Clinico-Pathological Characteristics on Recurrence-Free Survival in Nasopharyngeal Carcinoma

  • Muhammad Awawda,
  • Majd Hanna,
  • Ahmad Awawdi,
  • Saeed Salman,
  • Natali Shirron and
  • Salem Billan

15 December 2025

Background: Nasopharyngeal carcinoma (NPC) is an uncommon malignancy with a distinct geographical distribution. However, data from non-endemic areas are limited. This study aims to evaluate oncological outcomes and identify prognostic factors in a la...

  • Article
  • Open Access
1 Citations
648 Views
16 Pages

Early BCR::ABL1 Reduction as a Predictor of Deep Molecular Response in Pediatric Chronic-Phase Chronic Myeloid Leukemia

  • Xingchen Wang,
  • Wenbin An,
  • Chenmeng Liu,
  • Bang Zhang,
  • Yunlong Chen,
  • Yang Wan,
  • Xiaolan Li,
  • Lipeng Liu,
  • Fang Liu and
  • Wenyu Yang
  • + 8 authors

15 December 2025

Background: Tyrosine kinase inhibitors (TKIs) have transformed the prognosis of chronic myeloid leukemia (CML), but pediatric patients face unique challenges due to prolonged exposure. Early molecular response (EMR, BCR::ABL1 ≤ 10% at 3 months) is...

  • Article
  • Open Access
476 Views
12 Pages

Metabolomic Insights into Prostate Cancer Treatment and Relapse

  • Kristina Lundquist,
  • Henrik Antti and
  • Camilla Thellenberg Karlsson

15 December 2025

Background: High-risk prostate cancer is often treated with combined androgen deprivation therapy (ADT) and radiotherapy (RT). Blood biomarkers may enable treatments to be tailored to individual patients. Metabolomics, the study of small-molecule alt...

  • Article
  • Open Access
568 Views
16 Pages

Implementation Rates and Predictors of Compliance with Enhanced Recovery After Surgery Protocols in Gynecologic Oncology: A Prospective Multi-Institutional Cohort Study

  • Vasilios Pergialiotis,
  • Dimitrios Haidopoulos,
  • Alexandros Daponte,
  • Dimitrios Tsolakidis,
  • Stamatios Petousis,
  • Ioannis Kalogiannidis,
  • Dimitrios Efthymios Vlachos,
  • Vasilios Lygizos,
  • Maria Fanaki and
  • Nikolaos Thomakos
  • + 6 authors

15 December 2025

Background: The importance of integrating enhanced recovery after surgery protocols in gynecologic oncology has been proven in numerous studies. However, the actual adherence to protocol among institutions remains inconsistent in clinical practice, p...

  • Article
  • Open Access
415 Views
11 Pages

An Exploratory Retrospective Study on the Association of Radiotherapy with the Risk of Immune-Related Adverse Events in Esophageal and Esophagogastric Junction Cancer Patients Receiving Immunotherapy

  • Nobukazu Hokamura,
  • Takeo Fukagawa,
  • Ryoji Fukushima,
  • Takashi Kiyokawa,
  • Masahiro Horikawa,
  • Yuichi Igarashi,
  • Hironori Midorikawa,
  • Shinya Kaneshiro and
  • Kenshiro Shiraishi

15 December 2025

Background: Radiotherapy (RT) combined with immune checkpoint inhibitors (ICIs) has shown therapeutic benefits, and the potential for enhanced immune activation has raised concerns about increased immune-related adverse events (irAEs). The immunologi...

  • Article
  • Open Access
560 Views
14 Pages

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes

  • Henning Plage,
  • Nadine Biernath,
  • Kira Furlano,
  • Sarah Weinberger,
  • Jonathan Jeutner,
  • Annika Fendler,
  • Florian Roßner,
  • Simon Schallenberg,
  • Sefer Elezkurtaj and
  • Bernhard Ralla
  • + 17 authors

15 December 2025

Urinary bladder cancer is the tenth most common malignancy worldwide and represents a major global health burden [...]

  • Systematic Review
  • Open Access
543 Views
17 Pages

Intestinal-Type Adenocarcinoma Is a Rare Histotype of Vulvar Neoplasm: Systematic Review of the Literature

  • Alessio Colalillo,
  • Dominga Boccia,
  • Luigi Della Corte,
  • Daniele Neola,
  • Federica Rosato,
  • Silvia D’Ippolito,
  • Maria De Ninno,
  • Damiano Arciuolo,
  • Maurizio Guida and
  • Francesco Cosentino
  • + 1 author

14 December 2025

Background: Intestinal-type vulvar adenocarcinoma (VAIt) is an exceptionally rare form of primary vulvar cancer, characterized by histological features resembling mucinous colonic carcinomas, including villo-glandular structures composed of goblet an...

  • Review
  • Open Access
549 Views
15 Pages

Refining Surgical Standards: The Role of Robotic-Assisted Segmentectomy in Early-Stage Non-Small-Cell Lung Cancer

  • Masaya Nishino,
  • Hideki Ujiie,
  • Masaoki Ito,
  • Hana Oiki,
  • Shota Fukuda,
  • Mai Nishina,
  • Shuta Ohara,
  • Akira Hamada,
  • Masato Chiba and
  • Yasuhiro Tsutani
  • + 1 author

14 December 2025

Background: Recent trials, including JCOG0802/WJOG4607L and CALGB140503, have confirmed the oncological adequacy of segmentectomy for early-stage non-small-cell lung cancer (NSCLC). This shift emphasizes the preservation of pulmonary function and min...

of 3

XFacebookLinkedIn
Cancers - ISSN 2072-6694